PURPOSE: To evaluate the safety and efficacy of 5 seconds of mitomycin-C (MMC)
application during photorefractive keratectomy (PRK) for low myopia. SETTING: Basir Eye …

Photorefractive keratectomy (PRK) is considered a safe approach laser procedure with a
clinical significance in correcting myopia results. PRK requires removing the whole …

OBJECTIVE: To determine whether the duration of mitomycin C (MMC) 0.02% application
affects visual outcome or the incidence of subepithelial haze in patients undergoing …

Purpose: To evaluate the long-term corneal safety of topical mitomycin C (MMC) used during
photorefractive keratectomy to prevent haze formation in highly myopic eyes. Methods …

Purpose: To evaluate the outcome of primary or retreatment photorefractive keratectomy
(PRK) or photo-therapeutic keratectomy (PTK) with mitomycin C (MMC) 0.02% applied …

PURPOSE: To evaluate the effects of topical mitomycin-C (MMC) after hyperopic
photorefractive keratectomy (PRK). SETTING: Private practice, Siena, Italy. METHODS: In …

Abstract Purpose To compare MMC 0.002% efficacy in preventing haze after PRK in relation
to MMC 0.02%. Patients and methods We conducted a prospective study with patients with …

Purpose To evaluate the safety and efficacy of mitomycin-C (MMC) 0.01%(0.1 mg/mL) in
preventing haze formation after wavefront-guided photorefractive keratectomy (PRK) for …

Purpose To compare the variance in manifest refraction spherical equivalent (MRSE) after
photorefractive keratectomy (PRK) with mitomycin-C (MMC), PRK without MMC, and laser in …

PURPOSE: To determine whether there is an increased risk to the corneal endothelium
when mitomycin C (MMC) is administered after photorefractive keratectomy (PRK). DESIGN …